IL95136A0 - Lhrh analogs - Google Patents

Lhrh analogs

Info

Publication number
IL95136A0
IL95136A0 IL95136A IL9513690A IL95136A0 IL 95136 A0 IL95136 A0 IL 95136A0 IL 95136 A IL95136 A IL 95136A IL 9513690 A IL9513690 A IL 9513690A IL 95136 A0 IL95136 A0 IL 95136A0
Authority
IL
Israel
Prior art keywords
lhrh analogs
lhrh
analogs
Prior art date
Application number
IL95136A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL95136A0 publication Critical patent/IL95136A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL95136A 1989-08-07 1990-07-20 Lhrh analogs IL95136A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39057289A 1989-08-07 1989-08-07
US07/548,512 US5110904A (en) 1989-08-07 1990-07-10 Lhrh analogs

Publications (1)

Publication Number Publication Date
IL95136A0 true IL95136A0 (en) 1991-06-10

Family

ID=27013204

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95136A IL95136A0 (en) 1989-08-07 1990-07-20 Lhrh analogs

Country Status (12)

Country Link
US (1) US5110904A (no)
EP (1) EP0413209A1 (no)
JP (1) JPH03101695A (no)
KR (1) KR0144144B1 (no)
AU (2) AU6028690A (no)
CA (1) CA2022444C (no)
HU (1) HUT54387A (no)
IE (1) IE902740A1 (no)
IL (1) IL95136A0 (no)
NO (1) NO903455L (no)
PL (1) PL286388A1 (no)
PT (1) PT94924B (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
DE3936328A1 (de) * 1989-10-27 1991-05-02 Schering Ag Pharmazeutische praeparate
US5352796A (en) * 1989-10-30 1994-10-04 The Salk Institute For Biological Studies Amino acids useful in making GnRH analogs
US5296468A (en) * 1989-10-30 1994-03-22 The Salk Institute For Biological Studies GnRH analogs
DE59100945D1 (de) * 1990-08-04 1994-03-10 Hoechst Ag Gonadoliberin-Antagonisten.
US5744450A (en) 1991-03-14 1998-04-28 The Salk Institute For Biological Studies GnRH analogs
CA2108977C (en) * 1991-04-25 2002-12-17 Romano Deghenghi Luteinizing hormone releasing hormone antagonist peptides
CA2112566A1 (en) * 1991-07-01 1993-02-18 Graham J. Moore Non-desensitizing analogs of gnrh and other biologically active ligands
US5480969A (en) * 1992-09-15 1996-01-02 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
JPH08504209A (ja) * 1992-12-04 1996-05-07 アボツト・ラボラトリーズ ６位修飾デカペプチドｌｈｒｈ拮抗薬
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
UA61046C2 (en) * 1992-12-07 2003-11-17 Takeda Chemical Industries Ltd Sustained-release preparation and method for its manufacture
IL108509A0 (en) * 1993-02-22 1994-05-30 Salk Inst For Biological Studi GnRH antagonist peptides
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
US5413990A (en) * 1993-08-06 1995-05-09 Tap Pharmaceuticals Inc. N-terminus modified analogs of LHRH
CA2167834A1 (en) * 1993-08-06 1995-02-16 Fortuna Haviv N-terminus modified analogs of lhrh
US5594091A (en) * 1994-02-21 1997-01-14 Takeda Chemical Industries, Ltd. Matrix for sustained-release preparation
US5508383A (en) * 1994-03-09 1996-04-16 Tap Holdings Inc. Cyclic peptide LHRH antagonists
US5516759A (en) * 1994-12-08 1996-05-14 Tap Holdings Inc. LHRH antagonists having lactam groups at the N-terminus
US5681928A (en) * 1994-12-16 1997-10-28 The Salk Institute For Biological Studies Betides and methods for screening peptides using same
WO1996022786A1 (en) * 1995-01-23 1996-08-01 Takeda Chemical Industries, Ltd. Sustained-release preparation and use
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
US5710247A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process and intermediates for the synthesis of LHRH antagonists
US5710246A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process for intermediates for the synthesis of LHRH antagonists
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
US6297354B1 (en) 1998-08-12 2001-10-02 Abbott Laboratories Pentapeptide LHRH antagonists
US6191115B1 (en) 1998-08-12 2001-02-20 Abbott Laboratories C-terminus modified heptapeptide LHRH analogs
US5981521A (en) * 1998-11-13 1999-11-09 Abbott Laboratories Tetrahydroisoquinoline derivatives as LHRH antagonists
US6455499B1 (en) 1999-02-23 2002-09-24 Indiana University Foundation Methods for treating disorders associated with LHRH activity
DE19911771B4 (de) 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
US6673352B1 (en) * 1999-09-14 2004-01-06 The General Hospital Corporation Use of Mullerian inhibiting substance for treating excess androgen states
MXPA02008870A (es) 2000-03-14 2003-06-24 Zentaris Ag Novedosos antagonistas de lhrh, produccion de los mismos y sus uso como medicamentos.
EP1297850B1 (en) 2000-07-05 2015-08-19 Takeda Pharmaceutical Company Limited Medicinal preparations for treating sex hormone-dependent diseases
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
JP2004535431A (ja) * 2001-06-22 2004-11-25 サザン バイオシステムズ， インコーポレイテッド ゼロ次長期放出同軸インプラント
TWI225416B (en) 2001-06-29 2004-12-21 Takeda Chemical Industries Ltd Sustained-release composition and process for producing the same
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
WO2003041739A1 (en) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Anticaner agents
CA2478827A1 (en) * 2002-03-11 2003-09-18 Takeda Chemical Industries, Ltd. Remedies for sex hormone-dependent disease
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
WO2004017919A2 (en) * 2002-08-23 2004-03-04 The General Hospital Corporation Use of mullerian inhibiting substance and interferon for treating tumors
GB0326632D0 (en) 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
US20070106271A1 (en) * 2005-11-09 2007-05-10 Searete Llc, A Limited Liability Corporation Remote control of substance delivery system
WO2008066117A1 (fr) 2006-11-30 2008-06-05 Takeda Pharmaceutical Company Limited Composé amine cyclique
WO2010142060A1 (zh) * 2009-06-11 2010-12-16 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
RU2585101C2 (ru) 2010-04-01 2016-05-27 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Способ приготовления частиц носителя для сухих порошков для ингаляции
EP2611416B1 (en) 2010-09-03 2015-08-19 Pharmaterials Ltd. Pharmaceutical composition suitable for use in a dry powder inhaler
EP2873455B1 (en) 2012-07-12 2021-07-07 Takeda Pharmaceutical Company Limited Method for manufacturing microcapsule powder
EP3534974A4 (en) 2016-11-02 2020-07-01 Board of Regents, The University of Texas System DISSOLUBLE FILMS AND METHODS OF USING SAME

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU497512B2 (en) * 1975-04-15 1978-12-14 Ici Australia Limited Nona and deca-peptides
NZ188987A (en) * 1977-11-30 1982-02-23 Salk Inst For Biological Studi Peptide analogues of luteinizing hormone releasing factor
IT1149971B (it) * 1979-06-11 1986-12-10 Syntex Inc Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante
US4493934A (en) * 1979-10-01 1985-01-15 Merck & Co., Inc. 2(3-Amino-2-oxopyrrolidin-1-yl) acetic acid and n-acylated derivatives thereof
US4444759A (en) * 1982-07-26 1984-04-24 The Salk Institute For Biological Studies GnRH Antagonists II
US4547370A (en) * 1983-11-29 1985-10-15 The Salk Institute For Biological Studies GnRH Antagonists
US4632979A (en) * 1984-06-18 1986-12-30 Tulane Educational Fund Therapeutic LHRH analogs
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
US4690916A (en) * 1984-11-13 1987-09-01 Syntex (U.S.A.) Inc. Nona and decapeptide analogs of LHRH useful as LHRH antagonists
US5003011A (en) * 1985-04-09 1991-03-26 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4866160A (en) * 1985-04-09 1989-09-12 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
EP0400065B1 (en) * 1988-02-10 1997-08-27 TAP Pharmaceuticals Inc. Lhrh analog

Also Published As

Publication number Publication date
NO903455L (no) 1991-02-08
AU5789294A (en) 1994-05-26
NO903455D0 (no) 1990-08-06
PT94924A (pt) 1991-05-22
CA2022444C (en) 2002-01-15
JPH03101695A (ja) 1991-04-26
KR910004661A (ko) 1991-03-29
EP0413209A1 (en) 1991-02-20
HUT54387A (en) 1991-02-28
IE902740A1 (en) 1991-02-27
AU672474B2 (en) 1996-10-03
KR0144144B1 (ko) 1998-07-01
PL286388A1 (en) 1991-05-06
CA2022444A1 (en) 1991-02-08
US5110904A (en) 1992-05-05
PT94924B (pt) 1997-09-30
AU6028690A (en) 1991-02-07

Similar Documents

Publication Publication Date Title
IL95136A0 (en) Lhrh analogs
EP0417454A3 (en) Reduced size lhrh analogs
GB8909571D0 (en) Novel cyclopentano-vitamin d analogs
GB8908250D0 (en) Formulations
EP0400065A4 (en) Lhrh analogs
ZA907637B (en) Anthelmintics
ZA901879B (en) Medicament
GB2239636B (en) Self propelled roll-about
ZA909629B (en) Anthelmintics
ZA906956B (en) Anthelmintics
ZA907638B (en) Anthelmintics
AP9000174A0 (en) Antiparasitical formulations
EP0480918A4 (en) ANALOGS OF THE REDUCED-SIZE HORMONE RELEASE HORMONE.
ZA909630B (en) Anthelmintics
GB8910048D0 (en) Carry more
HU900965D0 (en) Alga-destroying produces
GB8923926D0 (en) Retie
IE891408L (en) Cyclopentano-vitamin d analogs
ZA908575B (en) Gnrh analogs
ZA892971B (en) Tyr-peptide analogs
ZA903647B (en) Nucleoside analogs
GB8615959D0 (en) Joysticks
ZA90840B (en) Medicament
GB8716540D0 (en) Spread
GB8909175D0 (en) Electro-therapy